Calypte Files Registration Statement WEDNESDAY, JUNE 16, 2004 9:59 AM - PR Newswire
CYPT 0.52 +0.02 Enter Symbol: Enter Keyword: ALAMEDA, Calif., Jun 16, 2004 /PRNewswire-FirstCall via COMTEX/ -- Calypte Biomedical Corporation (CYPT) , a developer, manufacturer and marketer of HIV diagnostic tests, today announced that it has filed a registration statement (the "Registration Statement") with the Securities and Exchange Commission registering shares of common stock purchased and shares of common stock underlying warrants purchased in its recent private placement (the "May 2004 PIPE"), as well as other unregistered shares of common stock, primarily owned by Marr Technologies BV, an affiliate of Calypte and its largest stockholder.
Calypte currently has approximately 164 million shares of common stock issued and outstanding, which includes approximately 71 million of the shares being registered pursuant to the Registration Statement. These shares being registered represent approximately 43% of the Company's currently issued and outstanding common stock. Of the 71 million shares, approximately 51 million are owned by affiliates of Calypte, and the balance by investors in the May 2004 PIPE other than affiliates of Calypte and other financings, as well as vendors and consultants who have received common stock in lieu of cash.
The Registration Statement provides for the issuance of an additional 12 million shares, which includes approximately 9 million shares to be held for issuance upon exercise of the warrants issued in the May 2004 PIPE. Affiliates of Calypte hold about 70% of those warrants.
|